Cargando…
Design, statistical analysis and sample size calculation of a phase IIb/III study of linagliptin versus voglibose and placebo
BACKGROUND: Many patients with diabetes mellitus (DM) require a combination of antidiabetic drugs with complementary mechanisms of action to lower their hemoglobin A(1c )levels to achieve therapeutic targets and reduce the risk of cardiovascular complications. Linagliptin is a novel member of the di...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743680/ https://www.ncbi.nlm.nih.gov/pubmed/19732457 http://dx.doi.org/10.1186/1745-6215-10-82 |